Xueqin Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xueqin Xie has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Hao Lin
School of Life Science and Technology and Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
6 shared publications - Fuying Dao
School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
4 shared publications - Changchun Wu
Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications - Dan Yan
Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
3 shared publications Hao Lyu
Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications- Benjamin Lebeau
School of Biological Sciences, Nanyang Technological University, Singapore, Republic of Singapore
2 shared publications
Latest Publications
- 1 September 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (12) , 3609-3623
Single-cell profiling of pancreatic islets maps subtype-associated molecular alterations in type 2 diabetes
- 1 September 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (12) , 3609-3623
Single-cell profiling of pancreatic islets maps subtype-associated molecular alterations in type 2 diabetes
- Open Access
- 31 August 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (5)
Navigating the 3D genome at single-cell resolution: techniques, computation, and mechanistic landscapes
The 3D organization of the genome is critical for gene expression regulation, cellular identity, and disease progression. Traditional methods that analyze bulk genomic data often obscure cell-to-cell heterogeneity, limiting the resolution of intrinsic variability within complex biological systems. To overcome this, single-cell 3D genomics has emerged, revealing chromatin architecture at the individual cell level. Advanced experimental approaches enable genome-wide chromatin contact mapping, while computational frameworks reconstruct dynamic chromatin topologies from high-dimensional data. Building on these breakthroughs, recent advances in single-cell 3D genomics have led to transformative progress in epigenetics, linking 3D genome architecture with gene regulation, cellular identity, and disease phenotypes. This review focuses on the breakthroughs in single-cell 3D genomics, demonstrating how integrated experimental, computational, and mechanistic approaches decode chromatin architecture. These insights have deepened the understanding of genome function at the single-cell level and lay the foundation for future advances in precision medicine and topology-guided therapeutic strategies.
- 31 August 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (5)
Open AccessNavigating the 3D genome at single-cell resolution: techniques, computation, and mechanistic landscapes
The 3D organization of the genome is critical for gene expression regulation, cellular identity, and disease progression. Traditional methods that analyze bulk genomic data often obscure cell-to-cell heterogeneity, limiting the resolution of intrinsic variability within complex biological systems. To overcome this, single-cell 3D genomics has emerged, revealing chromatin architecture at the individual cell level. Advanced experimental approaches enable genome-wide chromatin contact mapping, while computational frameworks reconstruct dynamic chromatin topologies from high-dimensional data. Building on these breakthroughs, recent advances in single-cell 3D genomics have led to transformative progress in epigenetics, linking 3D genome architecture with gene regulation, cellular identity, and disease phenotypes. This review focuses on the breakthroughs in single-cell 3D genomics, demonstrating how integrated experimental, computational, and mechanistic approaches decode chromatin architecture. These insights have deepened the understanding of genome function at the single-cell level and lay the foundation for future advances in precision medicine and topology-guided therapeutic strategies.
- Open Access
scRiskCell: A single‐cell framework for quantifying islet risk cells and their adaptive dynamics in type 2 diabetes
ScRiskCell is an interpretable intelligent computational framework that leverages nearly 500,000 islet cell expression profiles from 106 donors across different continuous disease states. By calculating the intrinsic relationship between donor disease states and cell expression profiles, it assigns a pseudo‐cell state index to each cell. Sorting the pseudo‐indexes of cells enables the identification of risk cells truly disrupted by the disease. Importantly, scRiskCell reveals the dynamic aggregation pattern of risk cells during disease progression, providing mechanistic insights for early disease prediction and clinical dynamic monitoring of disease progression.
Open AccessscRiskCell: A single‐cell framework for quantifying islet risk cells and their adaptive dynamics in type 2 diabetes
ScRiskCell is an interpretable intelligent computational framework that leverages nearly 500,000 islet cell expression profiles from 106 donors across different continuous disease states. By calculating the intrinsic relationship between donor disease states and cell expression profiles, it assigns a pseudo‐cell state index to each cell. Sorting the pseudo‐indexes of cells enables the identification of risk cells truly disrupted by the disease. Importantly, scRiskCell reveals the dynamic aggregation pattern of risk cells during disease progression, providing mechanistic insights for early disease prediction and clinical dynamic monitoring of disease progression.
- Open Access
RepliChrom: Interpretable machine learning predicts cancer‐associated enhancer‐promoter interactions using DNA replication timing
RepliChrom is an interpretable machine learning model that predicts enhancer‐promoter interactions using DNA replication timing across multiple cell types. By integrating replication timing with chromatin interaction data from multiple experimental platforms, it accurately distinguishes true interactions and reveals promoter‐region signals as key regulatory drivers. Importantly, the RepliChrom uncovers cancer‐specific chromatin patterns in leukemia, offering mechanistic insights into how replication timing shapes long‐range gene regulation in both normal and diseased genomes.
Open AccessRepliChrom: Interpretable machine learning predicts cancer‐associated enhancer‐promoter interactions using DNA replication timing
RepliChrom is an interpretable machine learning model that predicts enhancer‐promoter interactions using DNA replication timing across multiple cell types. By integrating replication timing with chromatin interaction data from multiple experimental platforms, it accurately distinguishes true interactions and reveals promoter‐region signals as key regulatory drivers. Importantly, the RepliChrom uncovers cancer‐specific chromatin patterns in leukemia, offering mechanistic insights into how replication timing shapes long‐range gene regulation in both normal and diseased genomes.
- 5 January 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 169, 107952
Predicting coronary heart disease in Chinese diabetics using machine learning
- 5 January 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 169, 107952
Predicting coronary heart disease in Chinese diabetics using machine learning